Incidence of hepatocellular carcinoma (HCC) and death in the study cohort
| Untreated | Interferon treated | ||
|---|---|---|---|
| SVR | Non-SVR | ||
| *Includes deaths not directly related to HCC in patients who had developed the cancer. | |||
| SVR, sustained virological response. | |||
| No of patients | 395 | 836 | 1556 |
| Follow up (y) | 6.5 (2.8) | 6.7 (3.0) | 7.4 (2.9) |
| HCC development (n) | 67 | 27 | 214 |
| Death (n) | 33 | 11 | 89 |
| With HCC (n)* | 22 | 6 | 59 |
| Hepatic deaths | |||
| Without HCC (n) | 4 | 1 | 8 |
| Non-hepatic deaths (n) | 7 | 4 | 22 |